Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 40 Records) |
| Query Trace: Glioma and PTEN[original query] |
|---|
| PTEN gene mutations correlate to poor prognosis in glioma patients: a meta-analysis. OncoTargets and therapy 2016 9 3485-92. Han Feng, Hu Rong, Yang Hua, Liu Jian, Sui Jianmei, Xiang Xin, Wang Fan, Chu Liangzhao, Song Shib |
| Sexual dimorphism in glioma glycolysis underlies sex differences in survival. JCI insight 2017 Aug 2 (15): . Ippolito Joseph E, Yim Aldrin Kay-Yuen, Luo Jingqin, Chinnaiyan Prakash, Rubin Joshua |
| Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma. Brain pathology (Zurich, Switzerland) 2018 Sep . Vizcaino M Adelita, Palsgrove Doreen N, Yuan Ming, Giannini Caterina, Cabrera-Aldana Eibar Ernesto, Pallavajjala Aparna, Burger Peter C, Rodriguez Fausto |
| Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma. Journal of neuro-oncology 2018 Apr . Wijnenga Maarten M J, French Pim J, Dubbink Hendrikus J, Dinjens Winand N M, Atmodimedjo Peggy N, Kros Johan M, Fleischeuer Ruth, Dirven Clemens M F, Vincent Arnaud J P E, van den Bent Martin |
| Racial Disparities in the Molecular Landscape of Cancer. Anticancer research 2018 04 38 (4): 2235-2240. Heath Elisabeth I, Lynce Filipa, Xiu Joanne, Ellerbrock Angela, Reddy Sandeep K, Obeid Elias, Liu Stephen V, Bollig-Fischer Aliccia, Separovic Duska, Vanderwalde A |
| Comprehensive analysis of Reverse Phase Protein Array data reveals characteristic unique proteomic signatures for glioblastoma subtypes. Gene 2018 11 685 85-95. Patil Vikas, Mahalingam Kulandaive |
| Receptor tyrosine kinase expression in high-grade gliomas before and after chemoradiotherapy. Oncology letters 2019 12 18 (6): 6509-6515. Wang Kuanyu, Huang Ruoyu, Wu Chenxing, Li Guanzhang, Zhao Zheng, Hu Huimin, Liu Yanw |
| Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation. BMC cancer 2019 Oct 19 (1): 968. Brito Cheila, Azevedo Ana, Esteves Susana, Marques Ana Rita, Martins Carmo, Costa Ilda, Mafra Manuela, Bravo Marques José M, Roque Lúcia, Pojo Mar |
| Clinical characterization, genetic profiling, and immune infiltration of TOX in diffuse gliomas. Journal of translational medicine 2020 Aug 18 (1): 305. Zhang Hao, Fan Fan, Yu Yuanqiang, Wang Zeyu, Liu Fangkun, Dai Ziyu, Zhang Liyang, Liu Zhixiong, Cheng Qu |
| A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas. Cancer science 2020 Aug . Higa Nayuta, Akahane Toshiaki, Yokoyama Seiya, Yonezawa Hajime, Uchida Hiroyuki, Takajo Tomoko, Kirishima Mari, Hamada Taiji, Matsuo Kei, Fujio Shingo, Hanada Tomoko, Hosoyama Hiroshi, Yonenaga Masanori, Sakamoto Akihisa, Hiraki Tsubasa, Tanimoto Akihide, Yoshimoto Ko |
| Molecular genetic profiling reveals novel association between FLT3 mutation and survival in glioma. Journal of neuro-oncology 2020 6 148 (3): 473-480. Shee Kevin, Chambers Meagan, Hughes Edward G, Almiron Damian A, Deharvengt Sophie J, Green Donald, Lefferts Joel A, Andrew Angeline S, Hickey William F, Tsongalis Gregory |
| Establishment and validation of an immune-based prognostic score model in glioblastoma. International immunopharmacology 2020 6 85 106636. Qin Zhigang, Zhang Xiuli, Chen Zhuo, Liu Naij |
| An Autophagy-Related Gene Signature Associated With Clinical Prognosis and Immune Microenvironment in Gliomas. Frontiers in oncology 2020 10 571189. Xu Yang, Li Renpeng, Li Xiaoxia, Dong Naijun, Wu Di, Hou Lin, Yin Kan, Zhao Chunh |
| Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 10 26 (24): 6600-6609. Carrato Cristina, Alameda Francesc, Esteve-Codina Anna, Pineda Estela, Arpí Oriol, Martinez-García Maria, Mallo Mar, Gut Marta, Lopez-Martos Raquel, Barco Sonia Del, Ribalta Teresa, Capellades Jaume, Puig Josep, Gallego Oscar, Mesia Carlos, Muñoz-Marmol Ana M, Archilla Ivan, Arumí Montserrat, Blanc Julie Marie, Bellosillo Beatriz, Menendez Silvia, Esteve Anna, Bagué Silvia, Hernandez Ainhoa, Craven-Bartle Jordi, Fuentes Rafael, Vidal Noemí, Aldecoa Iban, Iglesia Nuria de la, Balana Carm |
| Identification of the Prognostic Signatures of Glioma With Different PTEN Status. Frontiers in oncology 2021 8 11 633357. Zhang Pei, Meng Xinyi, Liu Liqun, Li Shengzhen, Li Yang, Ali Sakhawat, Li Shanhu, Xiong Jichuan, Liu Xuefeng, Li Shouwei, Xia Qin, Dong L |
| Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy. Frontiers in oncology 2021 11 640910. Hu Li, Cheng Xingbo, Binder Zev, Han Zhibin, Yin Yibo, O'Rourke Donald M, Wang Sida, Feng Yumeng, Weng Changjiang, Wu Anhua, Lin Zhig |
| Comprehensive Molecular Characterization of Chinese Patients with Glioma by Extensive Next-Generation Sequencing Panel Analysis. Cancer management and research 2021 5 13 3573-3588. Zeng Chun, Wang Jing, Li Mingwei, Wang Huina, Lou Feng, Cao Shanbo, Lu Chang |
| Environmental and sex-specific molecular signatures of glioma causation. Neuro-oncology 2021 5 24 (1): 29-36. Claus Elizabeth B, Cannataro Vincent L, Gaffney Stephen G, Townsend Jeffrey |
| Genomic Profiling Identified Novel Prognostic Biomarkers in Chinese Midline Glioma Patients. Frontiers in oncology 2020 10 607429. Li Hainan, Shan Changguo, Wu Shengnan, Cheng Baijie, Fan Chongzu, Cai Linbo, Chen Yedan, Shi Yuqian, Liu Kaihua, Shao Yang, Zhu Dan, Li Z |
| Glioma Imaging by O-(2-18F-Fluoroethyl)-L-Tyrosine PET and Diffusion-Weighted MRI and Correlation With Molecular Phenotypes, Validated by PET/MR-Guided Biopsies. Frontiers in oncology 2021 12 11 743655. Cheng Ye, Song Shuangshuang, Wei Yukui, Xu Geng, An Yang, Ma Jie, Yang Hongwei, Qi Zhigang, Xiao Xinru, Bai Jie, Xu Lixin, Hu Zeliang, Sun Tingting, Wang Leiming, Lu Jie, Lin Qingta |
| Molecular Genetic Profile of 300 Japanese Patients with Diffuse Gliomas Using a Glioma-tailored Gene Panel. Neurologia medico-chirurgica 2022 8 62 (9): 391-399. Higa Nayuta, Akahane Toshiaki, Yokoyama Seiya, Yonezawa Hajime, Uchida Hiroyuki, Fujio Shingo, Kirishima Mari, Takigawa Kosuke, Hata Nobuhiro, Toh Keita, Yamamoto Junkoh, Hanaya Ryosuke, Tanimoto Akihide, Yoshimoto Ko |
| A Targeted Next-Generation Sequencing Panel to Genotype Gliomas. Life (Basel, Switzerland) 2022 Jun 12 (7): . Guarnaccia Maria, Guarnaccia Laura, La Cognata Valentina, Navone Stefania Elena, Campanella Rolando, Ampollini Antonella, Locatelli Marco, Miozzo Monica, Marfia Giovanni, Cavallaro Sebastia |
| Dissecting and analyzing the Subclonal Mutations Associated with Poor Prognosis in Diffuse Glioma. BioMed research international 2022 5 2022 4919111. Bai Ming, Wang Xiaolong, Zhang Huixue, Wang Jianjian, Lyaysan Gaysina, Xu Si, Tian Kuo, Wang Tianfeng, Li Jie, Wang Na, Lu Xiaoyu, Zhang Xiaoming, Wang Lih |
| Immune Landscape in PTEN-Related Glioma Microenvironment: A Bioinformatic Analysis. Brain sciences 2022 4 12 (4): . Giotta Lucifero Alice, Luzzi Sabi |
| Exosomal PTEN as a Predictive Marker of Aggressive Gliomas. Neurology India 2022 3 70 (1): 215-222. Patnam Sreekanth, Samal Rasmita, Koyyada Rajeswari, Joshi Partha, Singh Anula D, Nagalla Balakrishna, Soma Madan R, Sannareddy Rajesh R, Ippili Kaushal, Raju Subodh, Boola Ratnam G, Lath Rahul, Ranjan Alok, Ghosh Siddharth, Balamurugan M, Ray Amitava, Manda Sasidhar |
| A prognostic risk model for glioma patients by systematic evaluation of genomic variations. iScience 2022 12 25 (12): 105681. Zhang Baifeng, Wan Weiqing, Li Zibo, Gao Zhixian, Ji Nan, Xie Jian, Wang Junmei, Wang Bin, Lai-Wan Kwong Dora, Guan Xinyuan, Gao Shengjie, Zhao Yuanli, Lu Youyong, Zhang Liwei, Rodland Karin D, Tsang Shirley |
| The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma. Frontiers in immunology 2022 13 998236. Wang Weichen, Lu Zhichao, Wang Maoyu, Liu Zongheng, Wu Bing, Yang Chengkai, Huan He, Gong Peip |
| Molecular profile and clinical features of patients with gliomas using a broad targeted next generation-sequencing panel. Oncology letters 2023 1 25 (1): 38. Romanidou Ourania, Apostolou Paraskevi, Kouvelakis Kyriakos, Tsangaras Kyriakos, Eliades Alexia, Achilleos Achilleas, Loizides Charalambos, Lemesios Christos, Ioannides Marios, Kypri Elena, Koumbaris George, Papadopoulou Kyriaki, Papathanasiou Athanasios, Rigakos Georgios, Xanthakis Ioannis, Fostira Florentia, Kotoula Vassiliki, Fountzilas George, Patsalis Philippos |
| Stromal protein CCN family contributes to the poor prognosis in lower-grade gioma by modulating immunity, matrix, stemness, and metabolism. Frontiers in molecular biosciences 2023 1 9 1027236. Liu Zhihui, Wu Jiasheng, Ji Hang, Zhao Hongtao, Wang Fang, Dong Jiawei, Zhang Jiheng, Wang Nan, Yan Xiuwei, Wang Kaikai, Hu Shaosh |
| GlioPredictor: a deep learning model for identification of high-risk adult IDH-mutant glioma towards adjuvant treatment planning. Scientific reports 2024 1 14 (1): 2126. Shuhua Zheng, Nikhil Rammohan, Timothy Sita, P Troy Teo, Yilin Wu, Maciej Lesniak, Sean Sachdev, Tarita O Thom |
- Page last reviewed:Feb 1, 2024
- Content source: